These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 8971103)

  • 1. Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease.
    Holmes C; Levy R; McLoughlin DM; Powell JF; Lovestone S
    J Neurol Neurosurg Psychiatry; 1996 Dec; 61(6):580-3. PubMed ID: 8971103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
    Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
    Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE ε4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death.
    Yu L; Boyle P; Schneider JA; Segawa E; Wilson RS; Leurgans S; Bennett DA
    Psychol Aging; 2013 Dec; 28(4):1015-23. PubMed ID: 23647000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA; Oulhaj A; de Jager CA; Williams JH
    Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.
    Craft S; Teri L; Edland SD; Kukull WA; Schellenberg G; McCormick WC; Bowen JD; Larson EB
    Neurology; 1998 Jul; 51(1):149-53. PubMed ID: 9674794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.
    van der Vlies AE; Koedam EL; Pijnenburg YA; Twisk JW; Scheltens P; van der Flier WM
    Psychol Med; 2009 Nov; 39(11):1907-11. PubMed ID: 19335933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
    Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
    Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala EL; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen PJ
    Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E polymorphism and age of onset for Alzheimer's disease in a bi-ethnic sample.
    Harwood DG; Barker WW; Ownby RL; St George-Hyslop P; Mullan M; Duara R
    Int Psychogeriatr; 2004 Sep; 16(3):317-26. PubMed ID: 15559755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of APOE ε4 and ε2 on plasma neurofilament light chain and cognition in autosomal dominant Alzheimer's disease.
    Langella S; Bonta K; Chen Y; Su Y; Vasquez D; Aguillon D; Acosta-Baena N; Baena AY; Garcia-Ospina G; Giraldo-Chica M; Tirado V; Muñoz C; Ríos-Romenets S; Guzman-Martínez C; Pruzin JJ; Ghisays V; Arboleda-Velasquez JF; Kosik KS; Tariot PN; Reiman EM; Lopera F; Quiroz YT
    Alzheimers Res Ther; 2024 Oct; 16(1):208. PubMed ID: 39354618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E genotype in sporadic early- and late-onset Alzheimer's disease.
    Masullo C; Daniele A; Seripa D; Filippini V; Gravina C; Carbone G; Gainotti G; Fazio VM
    Dement Geriatr Cogn Disord; 1998; 9(3):121-5. PubMed ID: 9621997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E polymorphisms in adults over 60 years of age with mild cognitive impairment and Alzheimer’s disease in different Venezuelan populations.
    Martínez S; Ochoa B; Pérez MR; Torrico F; García I; Garcia CC
    Biomedica; 2022 May; 42(Sp. 1):116-129. PubMed ID: 35866735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease.
    Drigalenko E; Poduslo S; Elston R
    Neurology; 1998 Jul; 51(1):131-5. PubMed ID: 9674791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOE ε4 carrier status and sex differentiate rates of cognitive decline in early- and late-onset Alzheimer's disease.
    Polsinelli AJ; Logan PE; Lane KA; Manchella MK; Nemes S; Sanjay AB; Gao S; Apostolova LG
    Alzheimers Dement; 2023 May; 19(5):1983-1993. PubMed ID: 36394443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of apolipoprotein E polymorphism in late-onset Alzheimer's disease and vascular dementia in Brazilians.
    Souza DR; de Godoy MR; Hotta J; Tajara EH; Brandão AC; Pinheiro Júnior S; Tognola WA; dos Santos JE
    Braz J Med Biol Res; 2003 Jul; 36(7):919-23. PubMed ID: 12845379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.
    Murphy GM; Taylor J; Kraemer HC; Yesavage J; Tinklenberg JR
    Am J Psychiatry; 1997 May; 154(5):603-8. PubMed ID: 9137113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E epsilon4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence.
    Jelic V; Julin P; Shigeta M; Nordberg A; Lannfelt L; Winblad B; Wahlund LO
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):59-65. PubMed ID: 9221969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.